The Raw Deal

opinion

Secondary market volatility is starting to be felt in the primary markets, where investors are pushing issuers onto the back foot in terms of price guidance. There was even one remarkable climb-down over Swiss agribusiness firm Syngenta’s covenant package.

Syngenta, rated A-, first approached the market with a €500 million 15-year deal, managed by CSFB, HSBC and Morgan Stanley. As the roadshow went on, however, it became clear that investors – who can’t pick up a copy of The Financial

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: